https://stock.noler.com/us/stock/meds https://stock.noler.com/us/stock/meds/13f-holdings https://stock.noler.com/us/stock/meds/accounts-receivable https://stock.noler.com/us/stock/meds/accounts-receivable-gross https://stock.noler.com/us/stock/meds/accounts-receivable-net https://stock.noler.com/us/stock/meds/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/meds/accrued-professional-fees-current https://stock.noler.com/us/stock/meds/accumulated-depreciation https://stock.noler.com/us/stock/meds/activist-13d-13g https://stock.noler.com/us/stock/meds/additional-paid-in-capital https://stock.noler.com/us/stock/meds/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/meds/adjustment-for-amortization https://stock.noler.com/us/stock/meds/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/meds/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/meds/amended-reports-10-k https://stock.noler.com/us/stock/meds/amortization https://stock.noler.com/us/stock/meds/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/meds/amortization-of-deferred-charges https://stock.noler.com/us/stock/meds/analyst-ratings-buy https://stock.noler.com/us/stock/meds/analyst-ratings-hold https://stock.noler.com/us/stock/meds/analyst-ratings-no-rating https://stock.noler.com/us/stock/meds/analyst-ratings-sell https://stock.noler.com/us/stock/meds/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/meds/asset-impairment-charges https://stock.noler.com/us/stock/meds/auditor https://stock.noler.com/us/stock/meds/basic-shares https://stock.noler.com/us/stock/meds/business https://stock.noler.com/us/stock/meds/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/meds/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/meds/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/meds/buybacks https://stock.noler.com/us/stock/meds/capitalized-computer-software-accumulated-amortization https://stock.noler.com/us/stock/meds/capitalized-computer-software-gross https://stock.noler.com/us/stock/meds/capitalized-computer-software-net https://stock.noler.com/us/stock/meds/capitalized-contract-cost-accumulated-impairment https://stock.noler.com/us/stock/meds/cash-acquired-from-acquisition https://stock.noler.com/us/stock/meds/cash-and-equivalents https://stock.noler.com/us/stock/meds/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/meds/cash-flow-breakdown https://stock.noler.com/us/stock/meds/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/meds/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/meds/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/meds/clinical-trials https://stock.noler.com/us/stock/meds/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/meds/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/meds/common-stock-value https://stock.noler.com/us/stock/meds/company-guidance https://stock.noler.com/us/stock/meds/company-profile https://stock.noler.com/us/stock/meds/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/meds/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/meds/contractual-obligation https://stock.noler.com/us/stock/meds/convertible-debt-current https://stock.noler.com/us/stock/meds/convertible-securities-retired https://stock.noler.com/us/stock/meds/cost-of-revenue https://stock.noler.com/us/stock/meds/cover-page-shares-outstanding https://stock.noler.com/us/stock/meds/current-assets https://stock.noler.com/us/stock/meds/current-liabilities https://stock.noler.com/us/stock/meds/current-portion-of-long-term-debt https://stock.noler.com/us/stock/meds/current-ratio https://stock.noler.com/us/stock/meds/debt-carrying-amount https://stock.noler.com/us/stock/meds/debt-convertible-conversion-price https://stock.noler.com/us/stock/meds/debt-equity-ratio https://stock.noler.com/us/stock/meds/debt-face-amount https://stock.noler.com/us/stock/meds/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/meds/debt-maturing-in-year-three https://stock.noler.com/us/stock/meds/debt-maturing-in-year-two https://stock.noler.com/us/stock/meds/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/meds/debt-unamortized-discount https://stock.noler.com/us/stock/meds/debt-unamortized-discount-current https://stock.noler.com/us/stock/meds/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/meds/deferred-costs https://stock.noler.com/us/stock/meds/deferred-costs-current https://stock.noler.com/us/stock/meds/deferred-tax-assets-gross https://stock.noler.com/us/stock/meds/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/meds/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/meds/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meds/deferred-tax-liabilities https://stock.noler.com/us/stock/meds/deposits-assets https://stock.noler.com/us/stock/meds/deposits-assets-noncurrent https://stock.noler.com/us/stock/meds/depreciation https://stock.noler.com/us/stock/meds/depreciation-and-amortization-expense https://stock.noler.com/us/stock/meds/diluted-shares https://stock.noler.com/us/stock/meds/dividend https://stock.noler.com/us/stock/meds/dividend-safety https://stock.noler.com/us/stock/meds/ebitda https://stock.noler.com/us/stock/meds/ebitda-margin https://stock.noler.com/us/stock/meds/effective-tax-rate https://stock.noler.com/us/stock/meds/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/meds/employee-benefits-and-share-based-compensation-noncash https://stock.noler.com/us/stock/meds/employee-count https://stock.noler.com/us/stock/meds/entity-listing-par-value-per-share https://stock.noler.com/us/stock/meds/eps https://stock.noler.com/us/stock/meds/eps-basic https://stock.noler.com/us/stock/meds/equity-method-investments https://stock.noler.com/us/stock/meds/executive-pay-pvp https://stock.noler.com/us/stock/meds/executive-salary-officers https://stock.noler.com/us/stock/meds/expense-breakdown https://stock.noler.com/us/stock/meds/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/meds/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/meds/fair-value-of-assets-acquired https://stock.noler.com/us/stock/meds/financing-cash-flow https://stock.noler.com/us/stock/meds/financing-receivable-percent-past-due https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-rolling-year-four https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-rolling-year-three https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/meds/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/meds/form-144-stocks https://stock.noler.com/us/stock/meds/form-n-port-stocks https://stock.noler.com/us/stock/meds/furniture-and-fixtures-gross https://stock.noler.com/us/stock/meds/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/meds/general-and-administrative-expense https://stock.noler.com/us/stock/meds/goodwill https://stock.noler.com/us/stock/meds/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/meds/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/meds/goodwill-impairment-loss https://stock.noler.com/us/stock/meds/graph https://stock.noler.com/us/stock/meds/gross-margin https://stock.noler.com/us/stock/meds/gross-profit https://stock.noler.com/us/stock/meds/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/meds/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/meds/included-in-etf https://stock.noler.com/us/stock/meds/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/meds/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/meds/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/meds/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/meds/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/meds/increase-decrease-in-inventories https://stock.noler.com/us/stock/meds/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/meds/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/meds/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/meds/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/meds/insider-transactions https://stock.noler.com/us/stock/meds/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/meds/interest-expense-nonoperating https://stock.noler.com/us/stock/meds/interest-paid-net https://stock.noler.com/us/stock/meds/interest-payable-current https://stock.noler.com/us/stock/meds/inventory https://stock.noler.com/us/stock/meds/inventory-adjustments https://stock.noler.com/us/stock/meds/inventory-finished-goods https://stock.noler.com/us/stock/meds/inventory-gross https://stock.noler.com/us/stock/meds/inventory-valuation-reserves https://stock.noler.com/us/stock/meds/inventory-write-down https://stock.noler.com/us/stock/meds/investing-cash-flow https://stock.noler.com/us/stock/meds/investments https://stock.noler.com/us/stock/meds/iran-activity-notices-irannotice https://stock.noler.com/us/stock/meds/labor-and-related-expense https://stock.noler.com/us/stock/meds/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/meds/leasehold-improvements-gross https://stock.noler.com/us/stock/meds/legal-fees https://stock.noler.com/us/stock/meds/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/meds/liabilities-assumed https://stock.noler.com/us/stock/meds/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/meds/litigation-settlement-expense https://stock.noler.com/us/stock/meds/long-term-debt https://stock.noler.com/us/stock/meds/long-term-loans-payable https://stock.noler.com/us/stock/meds/loss-on-contract-termination https://stock.noler.com/us/stock/meds/machinery-and-equipment-gross https://stock.noler.com/us/stock/meds/market-cap https://stock.noler.com/us/stock/meds/material-contracts https://stock.noler.com/us/stock/meds/net-change-in-cash https://stock.noler.com/us/stock/meds/net-fee-amt https://stock.noler.com/us/stock/meds/net-income https://stock.noler.com/us/stock/meds/net-margin https://stock.noler.com/us/stock/meds/news https://stock.noler.com/us/stock/meds/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/meds/notes-issued https://stock.noler.com/us/stock/meds/number-of-operating-segments https://stock.noler.com/us/stock/meds/number-of-reportable-segments https://stock.noler.com/us/stock/meds/operating-cash-flow https://stock.noler.com/us/stock/meds/operating-expenses https://stock.noler.com/us/stock/meds/operating-income https://stock.noler.com/us/stock/meds/operating-lease-assets https://stock.noler.com/us/stock/meds/operating-lease-liability https://stock.noler.com/us/stock/meds/operating-lease-liability-current https://stock.noler.com/us/stock/meds/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/meds/operating-lease-payments-due https://stock.noler.com/us/stock/meds/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/meds/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/meds/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/meds/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/meds/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/meds/operating-leases-rent-expense-net https://stock.noler.com/us/stock/meds/operating-loss-carryforwards https://stock.noler.com/us/stock/meds/operating-margin https://stock.noler.com/us/stock/meds/options-activity https://stock.noler.com/us/stock/meds/other-accrued-liabilities-current https://stock.noler.com/us/stock/meds/other-current-liabilities https://stock.noler.com/us/stock/meds/other-expenses https://stock.noler.com/us/stock/meds/other-income https://stock.noler.com/us/stock/meds/other-intangible-assets-net https://stock.noler.com/us/stock/meds/other-inventory https://stock.noler.com/us/stock/meds/other-liabilities https://stock.noler.com/us/stock/meds/other-noncurrent-assets https://stock.noler.com/us/stock/meds/other-nonoperating-income https://stock.noler.com/us/stock/meds/other-receivables-net-current https://stock.noler.com/us/stock/meds/other-short-term-borrowings https://stock.noler.com/us/stock/meds/outstanding-bonds https://stock.noler.com/us/stock/meds/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/meds/paid-in-capital-other https://stock.noler.com/us/stock/meds/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/meds/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/meds/patents-active https://stock.noler.com/us/stock/meds/payment-for-contingent-consideration-liability-investing-activities https://stock.noler.com/us/stock/meds/payments-for-fees https://stock.noler.com/us/stock/meds/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/meds/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/meds/pb-ratio https://stock.noler.com/us/stock/meds/pe-ratio https://stock.noler.com/us/stock/meds/pre-tax-margin https://stock.noler.com/us/stock/meds/preferred-shares https://stock.noler.com/us/stock/meds/prepaid-expense-current https://stock.noler.com/us/stock/meds/prepaid-expense-current-and-noncurrent https://stock.noler.com/us/stock/meds/pretax-income https://stock.noler.com/us/stock/meds/previous-etf-holding-it https://stock.noler.com/us/stock/meds/price-fcf-ratio https://stock.noler.com/us/stock/meds/proceeds-from-convertible-debt https://stock.noler.com/us/stock/meds/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/meds/proceeds-from-issuance-of-commercial-paper https://stock.noler.com/us/stock/meds/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/meds/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/meds/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/meds/proceeds-from-notes-payable https://stock.noler.com/us/stock/meds/proceeds-from-other-equity https://stock.noler.com/us/stock/meds/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/meds/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/meds/proceeds-from-stock-issued https://stock.noler.com/us/stock/meds/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/meds/profit-breakdown https://stock.noler.com/us/stock/meds/property-plant-and-equipment-gross https://stock.noler.com/us/stock/meds/property-plant-equipment https://stock.noler.com/us/stock/meds/provision-for-doubtful-accounts https://stock.noler.com/us/stock/meds/provision-for-other-credit-losses https://stock.noler.com/us/stock/meds/ps-ratio https://stock.noler.com/us/stock/meds/public-float https://stock.noler.com/us/stock/meds/quick-ratio https://stock.noler.com/us/stock/meds/repayments-of-lines-of-credit https://stock.noler.com/us/stock/meds/repayments-of-notes-payable https://stock.noler.com/us/stock/meds/repayments-of-other-short-term-debt https://stock.noler.com/us/stock/meds/retained-earnings https://stock.noler.com/us/stock/meds/return-on-tangible-equity https://stock.noler.com/us/stock/meds/revenue https://stock.noler.com/us/stock/meds/revenue-breakdown https://stock.noler.com/us/stock/meds/roa https://stock.noler.com/us/stock/meds/roe https://stock.noler.com/us/stock/meds/roi https://stock.noler.com/us/stock/meds/scorecard https://stock.noler.com/us/stock/meds/sec-comment-letters-upload https://stock.noler.com/us/stock/meds/sec-enforcement-actions https://stock.noler.com/us/stock/meds/sec-filings-10-q https://stock.noler.com/us/stock/meds/sec-filings-25-nse https://stock.noler.com/us/stock/meds/sec-filings-8-k https://stock.noler.com/us/stock/meds/sec-filings-px14a6g https://stock.noler.com/us/stock/meds/sec-filings-s-4 https://stock.noler.com/us/stock/meds/secondary-offerings https://stock.noler.com/us/stock/meds/secured-debt-current https://stock.noler.com/us/stock/meds/security-deposit https://stock.noler.com/us/stock/meds/selling-and-marketing-expense https://stock.noler.com/us/stock/meds/share-price https://stock.noler.com/us/stock/meds/shareholders-equity https://stock.noler.com/us/stock/meds/shares-authorized https://stock.noler.com/us/stock/meds/shares-issued https://stock.noler.com/us/stock/meds/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/meds/shares-issued-shares-new-issues https://stock.noler.com/us/stock/meds/shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/meds/shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/meds/shares-outstanding https://stock.noler.com/us/stock/meds/short-sale-volume https://stock.noler.com/us/stock/meds/short-term-debt https://stock.noler.com/us/stock/meds/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/meds/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/meds/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/meds/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/meds/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/meds/stock-based-compensation https://stock.noler.com/us/stock/meds/stock-issued-new-shares-sold https://stock.noler.com/us/stock/meds/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/meds/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/meds/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/meds/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/meds/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/meds/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/meds/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/meds/stock-splits https://stock.noler.com/us/stock/meds/subsidiaries https://stock.noler.com/us/stock/meds/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/meds/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meds/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/meds/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/meds/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meds/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/meds/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/meds/total-assets https://stock.noler.com/us/stock/meds/total-contract-liability https://stock.noler.com/us/stock/meds/total-liabilities https://stock.noler.com/us/stock/meds/total-liabilities-and-equity https://stock.noler.com/us/stock/meds/total-long-term-debt https://stock.noler.com/us/stock/meds/ttl-fee-amt https://stock.noler.com/us/stock/meds/ttl-offering-amt https://stock.noler.com/us/stock/meds/ttl-offset-amt https://stock.noler.com/us/stock/meds/ttl-prevsly-pd-amt https://stock.noler.com/us/stock/meds/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/meds/warrants-and-rights-outstanding